Free tool · 3-minute quiz
Rosacea subtype self-test.
Rosacea isn't one condition — it's four clinically distinct subtypes (ETR, papulopustular, phymatous, ocular) that need very different treatment. The wrong subtype assumption is why most people's rosacea routine plateaus. Answer 9 questions and we'll sort you into the most likely pattern with specific next steps for each.
Rosacea isn't a single condition — it's a family of related chronic skin inflammation patterns that the National Rosacea Society sorts into four clinical subtypes. The treatment for each is different, sometimes radically so. Generic "rosacea creams" sold to broad audiences fail half the people who buy them because the people don't know which subtype they actually have.
The four rosacea subtypes
The 2017 National Rosacea Society Expert Committee classification recognizes four distinct clinical subtypes. Many people have features of more than one, but identifying the dominant pattern guides treatment.
Subtype 1: Erythematotelangiectatic Rosacea (ETR)
Persistent central facial redness, often with visible small blood vessels (telangiectasia). Frequent flushing. Skin feels hot, sometimes stings. Few or no breakouts.
- Best evidence-based topicals: brimonidine 0.33% gel (Mirvaso) for acute flushing, oxymetazoline 1% (Rhofade) for persistent redness. Both work within hours but wear off.
- Visible blood vessels need laser — no topical addresses them. Pulsed-dye laser (PDL) or intense pulsed light (IPL) typically requires 3-5 sessions.
- Skin barrier care is critical — avoid harsh actives, fragrances, hot water, and strong AHA/BHA.
Subtype 2: Papulopustular Rosacea (PPR)
Persistent redness plus inflammatory papules (red bumps) and pustules. Often mistaken for adult acne — and treated with the wrong products as a result. This is the subtype with the most evidence-based topical options.
- First-line topicals: azelaic acid 15% gel (Finacea), ivermectin 1% cream (Soolantra), metronidazole 0.75-1%. All have decades of clinical data.
- Oral options for moderate-severe cases: doxycycline 40mg modified-release (Oracea) is the standard. Sub-antimicrobial dose — anti-inflammatory action without antibiotic resistance concern.
- Standard acne treatments (benzoyl peroxide, salicylic acid) can worsen PPR by aggravating the underlying inflammation.
Subtype 3: Phymatous Rosacea
Skin thickening, irregular surface nodules, enlarged sebaceous gland appearance — most commonly on the nose (rhinophyma). Far more common in men than women. Progressive without treatment.
- Early phymatous changes respond to oral isotretinoin at low doses.
- Advanced rhinophyma typically requires surgical reshaping — CO2 laser, electrosurgery, or dermabrasion.
- Earlier intervention produces better cosmetic outcomes. Don't wait years to see a dermatologist.
Subtype 4: Ocular Rosacea
Eye involvement — dry, gritty, burning eyes, swollen eyelids, recurrent styes, light sensitivity. Often present with one of the other subtypes but sometimes occurs alone. Underdiagnosed because patients don't connect eye symptoms to a skin condition.
- Needs both ophthalmology and dermatology input.
- Warm compresses, lid hygiene, artificial tears are the daily baseline.
- Oral doxycycline is often prescribed for the anti-inflammatory effect on the meibomian glands.
- Untreated ocular rosacea can cause corneal damage. This is the one rosacea subtype where delay has real medical consequences.
Why subtype identification matters
The same person might:
- Be using a generic "rosacea cream" with metronidazole that's helping their papules (good for PPR) but not touching their flushing (which needs brimonidine for ETR symptoms)
- Be on oral antibiotics for skin without anyone connecting the dots to their eye symptoms (ocular)
- Be trying barrier-repair routines for phymatous skin changes that need actual procedural intervention
Treatment that doesn't match your subtype plateaus. The tool below identifies the most likely dominant pattern and surfaces the specific next-step options for that pattern.
Common trigger patterns across subtypes
All rosacea subtypes share some common triggers, though intensity varies:
- Heat and temperature shifts — hot showers, hot weather, cold-to-warm transitions
- Alcohol, particularly red wine (the most-reported trigger in patient surveys)
- Spicy food — capsaicin specifically
- Sun exposure — broadband UV plus visible light
- Stress and emotional arousal
- Vigorous exercise
- Certain skincare ingredients — fragrances, alcohol denat, menthol, witch hazel, harsh exfoliants
- Topical steroids — can cause steroid rosacea that mimics PPR
Trigger identification is highly individual. Some people flare from one drink of red wine; others can drink without issue but flare from a 5-minute walk in the cold. A trigger diary kept for 4-6 weeks often surfaces a top-3 personal pattern that generic lists miss.
What about skin of color?
Rosacea is underdiagnosed in Fitzpatrick IV-VI skin because the redness is visually masked by underlying pigment. Symptoms more prominent in skin of color: papules and pustules (PPR features), persistent warmth, eye symptoms, granulomatous variant (firm papules). If a clinician dismisses "you don't look red enough to have rosacea" — find a different clinician. The Skin of Color Society maintains specialist directories.
When to see a dermatologist
- You've been treating "adult acne" for 12+ weeks without response — could be PPR misdiagnosed
- Persistent central facial redness for 3+ months
- Any eye symptoms paired with facial redness
- Skin thickening or surface change on the nose
- You're noticing rapid flares and want a trigger workup with someone who knows rosacea
Common questions about rosacea subtypes
How many types of rosacea are there?
Four clinical subtypes per the 2017 National Rosacea Society Expert Committee: erythematotelangiectatic (ETR — redness and visible vessels), papulopustular (PPR — bumps and pustules), phymatous (skin thickening, often on the nose), and ocular (eye involvement). Many patients have overlapping features, but identifying the dominant subtype guides treatment because each responds to different interventions.
What's the difference between ETR and PPR rosacea?
ETR is dominated by persistent central facial redness and visible blood vessels, with few or no inflammatory bumps. PPR adds red papules and pustules to the redness picture. ETR responds to topical vasoconstrictors (brimonidine, oxymetazoline) and laser for visible vessels. PPR responds to anti-inflammatory topicals (azelaic acid, ivermectin, metronidazole) and oral doxycycline. The treatment overlap is partial — getting the subtype right speeds up clearance.
Can I have more than one rosacea subtype?
Yes — overlapping subtypes are common. About 30% of PPR patients also have ETR features. Ocular rosacea frequently coexists with one of the cutaneous subtypes. The 2017 classification was specifically updated to acknowledge that the subtypes aren't always mutually exclusive — many patients sit on a spectrum.
Is rosacea on the nose always phymatous?
No. Nasal redness, visible blood vessels, and even pustules on the nose can be ETR or PPR. Phymatous rosacea specifically refers to texture and structural changes — skin thickening, irregular surface, sebaceous gland enlargement — that progress slowly over years. If your nose is red but the surface is smooth, that's not phymatous.
How is rosacea diagnosed in darker skin tones?
Diagnosis in Fitzpatrick IV-VI requires looking at features beyond redness — which is harder to see against underlying pigment. Diagnostic features more reliable in skin of color: warmth or burning sensation, papules and pustules, eye symptoms, the granulomatous variant (firm papules in a perioral distribution). Rosacea is significantly underdiagnosed in patients of color partly because clinicians anchor on visual redness. The Skin of Color Society maintains a specialist directory.
What's ocular rosacea?
Eye involvement in rosacea: chronic dry/gritty eyes, burning, light sensitivity, swollen eyelids, recurrent styes, and sometimes blurred vision. The meibomian glands (oil glands of the eyelids) are particularly affected. Roughly 50-75% of cutaneous rosacea patients have some ocular involvement; many don't realize the connection. Untreated ocular rosacea can cause corneal damage, making this the one subtype where delay has direct medical (not just cosmetic) consequences.